Scipher Medicine Partners with Top Pharma to Integrate Precision Medicine in Trials Read More » June 11, 2025
England’s NICE recommends FILSPARI as a treatment option for IgA nephropathy Read More » May 23, 2025
FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi Read More » May 19, 2025
